Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
Aberrant glycosylation actively contributes to tumor progression and is a key hallmark of cancer. Most of the glycan moieties expressed on the surface of cancer cells are sialic acids that may modulate antitumor immune responses via binding to sialic acid–binding immunoglobulin-like lectins (Siglecs...
Guardado en:
Autores principales: | Sulayman Benmerzoug, Mathieu F. Chevalier, Laura Villier, Sylvain Nguyen, Valérie Cesson, Anna K. Schneider, Florence Dartiguenave, Sonia-Christina Rodrigues-Dias, Ilaria Lucca, Patrice Jichlinski, Beat Roth, Denise Nardelli-Haefliger, Laurent Derré |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/66cfbf05dc5a4c1abdec773b93fd4a9e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Siglecs as Therapeutic Targets in Cancer
por: Jackwee Lim, et al.
Publicado: (2021) -
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Hyeree Choi, et al.
Publicado: (2021) -
Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity
por: Charles T. Lutz, et al.
Publicado: (2021) -
Neoadjuvant Therapy Using Checkpoint Inhibitors before Radical Cystectomy for Muscle Invasive Bladder Cancer: A Systematic Review
por: Hadi SHSM, et al.
Publicado: (2021) -
Occurrence of killer yeast strains in industrial and clinical yeast isolates
por: BAEZA,MARCELO E, et al.
Publicado: (2008)